Turn Therapeutics Inc. Retained Earnings
Turn Therapeutics Inc. (TTRX) had Retained Earnings of -$29.21 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-12
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$29.21M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$23.36M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$22.39M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$22.67M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$29.21M 10-Q · filed 2026-08-12 |
| 2026-03-31 | -$23.36M 10-Q · filed 2026-05-11 |
| 2025-12-31 | -$22.39M 10-Q · filed 2026-08-12 |
| 2025-09-30 | -$22.67M 10-Q · filed 2025-11-13 |
| 2024-12-31 | -$19.20M 10-K · filed 2026-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |